feed,title,long_url,short_url
Benzinga,Genmab Announces Phase 3 Trial of Tisotumab Vedotin in Recurrent or Metastatic Cervical Cancer,https://www.benzinga.com/pressreleases/21/01/g19005247/genmab-announces-phase-3-trial-of-tisotumab-vedotin-in-recurrent-or-metastatic-cervical-cancer,https://j.mp/3ogm6y3
